Case Study: Novartis achieves faster, more accurate safety signal detection and interactive exploratory data analysis with TIBCO Software's Spotfire

Novartis Uses TIBCO Spotfire for Exploratory Data Analysis and Safety Assessment in Preclinical and Clinical Studies

Novartis, a global pharmaceutical company headquartered in Basel, faced slow, iterative safety-assessment workflows that relied on static tables and programmer-generated graphics. Those traditional processes could take weeks, risk overlooking multi-dimensional safety signals, and created repeated "team <> analyst" loops across preclinical and clinical studies.

By deploying TIBCO Spotfire for interactive graphical data exploration, Novartis established repeatable workflows that let scientists and cross‑functional teams drill down from population trends to subject-level profiles, generate and test hypotheses, and identify dose–response relationships and at‑risk subgroups more quickly. The result was faster, more focused analyses, improved detection and systematic assessment of safety signals, and higher‑quality visualizations for study reports and regulatory submissions.

Novartis

Michael Merz

Head Safety Networks